Nomogram prediction for epidermal growth factor receptor mutation and subtypes in patients with non-small cell lung cancer

Author:

Li Wenbo1,Lei Haike2,Zhang Yangli1,Ju Linju1,Chen Zheng1,Chen Xueping1,Xiang Tingxiu2,Wu Zhongjun1

Affiliation:

1. The First Affiliated Hospital of Chongqing Medical University

2. Chongqing University Cancer Hospital

Abstract

Abstract

Objective: The aim of this study was to develop a nomogram model for predicting epidermal growth factor receptor (EGFR) mutations and their common subtypes in non-small cell lung cancer (NSCLC) patients. Methods: We conducted this study using data from NSCLC patients at the First Affiliated Hospital of Chongqing Medical University in China, including a total of 557 NSCLC patients. We identified independent risk factors for predicting EGFR mutations and their common subtypes through logistic univariable and multivariable analyses. These factors were then integrated to construct a nomogram, which underwent internal validation. We assessed the nomogram's predictive performance using receiver operating characteristic (ROC) curves and calibration plots. We randomly divided the dataset into training (n = 390) and validation (n = 167) cohorts in a 7:3 ratio. Following univariate and multivariate analyses, the nomogram for predicting EGFR mutations included four independent risk factors: age, pathological pattern (adenocarcinoma, ADC), smoking status, and squamous cell carcinoma antigen (SCC) levels. The nomogram for predicting EGFR exon 19 deletion mutation (19-Del) incorporated four independent risk factors: pathological pattern, smoking status, the presence of cytokeratin 21 fragment (CYFRA21.1), and tumor node metastasis (TNM). The nomogram for predicting EGFR exon 21-L858R mutation (21-L858R) included five independent risk factors: age, tumor location, pathological pattern, smoking status, and TNM. Results: In the nomogram for predicting EGFR mutations, the C-index of the nomogram model was 0.769 in the training cohort and 0.757 in the validation cohort. In the nomogram for predicting EGFR exon 19 deletion mutation, the C-index of the nomogram model was 0.673 in the training cohort and 0.743 in the validation cohort. In the nomogram for predicting EGFR exon 21-L858R mutation (21-L858R), the C-index of 0.745 in the training cohort and 0.641 in the validation cohort. The calibration plot of the nomogram shows a good agreement between the predicted probability and the actual probability. Conclusion: We have successfully developed and validated a novel nomogram for predicting EGFR mutation subtypes in NSCLC patients. This nomogram accurately estimates the EGFR mutation subtype and can help identify patients who may benefit from specific, individualized therapies.

Publisher

Springer Science and Business Media LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3